Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

NIH 49INDUSTRY 7OTHER 5NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Sarcoma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 171Vincristine 162Carboplatin 153Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 71Magnetic Resonance Spectroscopy 64Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × alvocidib × Clear all
NCT00005074 2020-04-09

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

Canadian Cancer Trials Group

Phase 2 Completed
33 enrolled
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

NCT00005971 2020-04-09

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Canadian Cancer Trials Group

Phase 2 Completed
17 enrolled
Dermatologic

Melanoma

NCT00005974 2020-04-08

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Canadian Cancer Trials Group

Phase 2 Completed
18 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡